January 06, 2025

Female Vulnerability to Alzheimer’s Linked to Unique Genetic Pathways

Neuropathology-based genetic study links disrupted lipid metabolism and immune dysfunction to Alzheimer’s.

Conexiant

December 27, 2024

The Retina as a Window to Alzheimer’s: Study Highlights Key Microglial Changes

Using advanced machine learning, researchers examine microglial morphology in Alzheimer’s, revealing novel insights into disease mechanisms.

Conexiant

December 26, 2024

Study Links Dopamine Dysregulation to Chronic Pain

New research uncovers how the loss of JMJD3, a key histone demethylase, disrupts dopamine production and amplifies chronic inflammatory pain in mice, offering insights into potential therapeutic targets.

Conexiant

December 26, 2024

Advancing Small-Cell Lung Cancer Care with Molecular Subtyping

Study of 195 SCLC patients emphasizes the diagnostic and therapeutic potential of 4 molecular subtypes and associated biomarkers.

Conexiant

December 20, 2024

Riluzole Shows Promise in Reversing Cognitive Decline from Radiation Therapy

Boosting brain-derived neurotrophic factor (BDNF) with riluzole may mitigate cognitive dysfunction from radiation therapy.

Conexiant

December 18, 2024

Understanding the 2022 WHO Classification of Endocrine Tumors

From the parathyroid to adrenal glands and thyroid tumors, the latest WHO classification introduces essential updates to tumor nomenclature and diagnostic criteria.

Conexiant

December 13, 2024

MTAP Deficiency: A New Biomarker and Therapeutic Target in Aggressive Urothelial Bladder Cancer

With MTAP loss predictive of worse outcomes, researchers explore precision therapies and diagnostic advancements in bladder cancer.

Conexiant

November 07, 2024

AI in Neuropathology: How Language Models Are Transforming Brain Tumor Diagnosis

New research explores how integrating AI with clinical guidelines can enhance diagnostic precision for complex brain tumors.

Conexiant

September 30, 2024

New DNA Test Accurately Differentiates Between Thymic Tumors

Misdiagnosis can lead to inappropriate treatment, potentially subjecting patients to unnecessary toxicity or, conversely, inadequate treatment for a life-threatening cancer.

Conexiant